According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. “
Several other research analysts have also recently issued reports on the company. Standpoint Research started coverage on Mazor Robotics in a research report on Friday, July 8th. They issued a buy rating and a $30.00 target price on the stock. Barclays PLC raised their target price on Mazor Robotics from $16.00 to $23.00 and gave the stock an overweight rating in a research report on Thursday, July 14th. Needham & Company LLC reissued a hold rating on shares of Mazor Robotics in a research report on Wednesday, October 12th. Finally, B. Riley started coverage on Mazor Robotics in a research report on Thursday, October 6th. They issued a neutral rating and a $25.00 target price on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $26.25.
Mazor Robotics (NASDAQ:MZOR) opened at 23.22 on Friday. The company’s market capitalization is $503.25 million. Mazor Robotics has a 52-week low of $8.31 and a 52-week high of $26.55. The company has a 50 day moving average of $23.40 and a 200 day moving average of $18.61.
Mazor Robotics (NASDAQ:MZOR) last announced its earnings results on Tuesday, August 2nd. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.02. The business had revenue of $8.30 million for the quarter, compared to analysts’ expectations of $8.51 million. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the firm posted ($0.05) earnings per share. On average, equities research analysts forecast that Mazor Robotics will post ($0.71) earnings per share for the current fiscal year.
A number of hedge funds have recently modified their holdings of MZOR. EAM Investors LLC acquired a new stake in shares of Mazor Robotics during the second quarter valued at about $2,348,000. Iguana Healthcare Management LLC increased its stake in shares of Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock valued at $1,507,000 after buying an additional 96,151 shares during the period. Candriam Luxembourg S.C.A. acquired a new stake in shares of Mazor Robotics during the second quarter valued at about $1,079,000. Menta Capital LLC increased its stake in shares of Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock valued at $466,000 after buying an additional 16,879 shares during the period. Finally, Cookson Peirce & Co. Inc. acquired a new stake in shares of Mazor Robotics during the second quarter valued at about $192,000. 18.72% of the stock is currently owned by institutional investors.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.